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ABSTRACT 
Cherenkov radiation has had various applications in high-energy physics since 
its discovery, and this research explores two applications of Cherenkov radiation 
relating to its presence in media under irradiation by medical radiotherapy beams. 
In real-time organic scintillating fiber dosimeters, the radiation fluence passing 
through the scintillating fibers produces Cherenkov light noise in addition to the 
scintillation light signal. Quantifying the Cherenkov light through Monte Carlo 
simulations allows us to optimize various parameters of the device, such as the 
spectral sensitivity profile of the photodetector attached to the end of the fiber and 
the fiber's shape, thickness, and emission spectrum, which allows full 
characterization of the Cherenkov noise in the scintillation-based detector. A second 
application attempts to directly measure the irradiation of surface cutaneous tissue 
by imaging the Cherenkov light emitted from the skin surface. The optical 
properties of the Cherenkov emission depend on the concentration of molecular 
absorbers in the epidermal and dermal layers of the skin, the optical scatter in the 
epidermis, and the distribution of high-energy electrons propagating through the 
cutaneous tissue, and the Cherenkov signal carries information on erythema 
development and the treatment response. 
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CHAPTER 1: GENERAL INTRODUCTION 
 Introduction 
Real-time imaging dosimetry in external beam radiation therapy can 
enhance patient safety. External beam radiation therapy uses a megavoltage 
electron linear accelerator to produce either a scattered electron beam or a 
bremsstrahlung x-ray beam to treat patients. The purpose of real-time 
imaging dosimetry is to enhance patient safety by detecting major errors 
during treatment delivery and by verifying the accuracy of the treatment 
delivered, which is achieved by monitoring the delivered dose distribution for 
significant deviations from the planned dose distribution. The purpose of my 
research is to assess the dosimetric properties of Cherenkov radiation for 
external megavoltage radiation therapy applications using two real-time 
imaging applications. 
One such method of real-time dosimetry measures the dose transmitted 
through organic scintillating fibers as the beam exits the linear accelerator 
and passes through a gantry mounted dosimeter. In organic polymer 
scintillating fiber optic dosimetry, ionizing electrons that cross the fiber 
generate scintillation light in proportion to the energy deposited within the 
fiber’s core material, and the light output intensity is proportional to the dose 
deposited in the material, which is nearly water equivalent. 
One potential problem with scintillating fiber dosimetry for external, 
megavoltage beams is the generation of Cherenkov radiation in addition to 
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the scintillation light. Cherenkov radiation is a continuous spectrum of low-
energy, electromagnetic radiation generated in a dielectric medium by the 
passage of a charged particle with a velocity greater than the phase velocity 
of light propagating through that medium, and the amount of Cherenkov 
radiation produced per unit pathlength varies with the charged particle 
energy. In a scintillating fiber dosimeter, the passage of electrons through the 
organic material induces Cherenkov radiation generation in addition to the 
production of scintillation light. The added Cherenkov radiation distorts the 
relationship between dose and Cherenkov light, and accurate dosimetry 
requires methods to account for the Cherenkov component of the signal. 
Another emerging method of real-time dosimetry in external beam 
megavoltage radiation therapy is the measurement of Cherenkov photons 
emitted directly from the patient’s skin during the treatment from 
interactions of electrons with the skin tissue.1  The Cherenkov light 
backscattered from the patient can be directly imaged with optical cameras 
for a variety of dosimetric or biological applications. 
 One technical challenge of this method is to accurately define the 
relationship between Cherenkov light intensity and the incident beam 
intensity.2  Specifically of interest is the amount of Cherenkov light intensity 
that reaches the skin surface before being absorbed in tissue and then is 
subsequently emitted in a direction that can be imaged by a high resolution 
camera outside of the interference of the radiation beam. 
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The purpose of my research is to assess the properties of Cherenkov 
radiation involved in these two real-time imaging dosimetry applications for 
external beam megavoltage radiation therapy. I programmed the simulation 
model using Monte Carlo techniques for radiation transport into the 
dosimetry medium, and the simulation results allow evaluation of the 
imaging-related properties of each method. The first application I examined 
was the minimally-perturbing polymer fiber array positioned in the beam 
during treatment to measure the beam output spatial distribution. Then I 
examined the application involving Cherenkov radiation backscatter and 
emission from patient skin inherently induced by external beam 
radiotherapy. 
For the first application, the objective is characterizing Cherenkov 
radiation produced in polymer fiber, real-time, imaging dosimeters, and the 
development of a model for the signal generated by the dosimeter for a given 
incident beam for various setup parameters. To realize this objective, I 
constructed a Monte Carlo program for the beam interactions in the 
scintillation fiber that accounts for the Cherenkov radiation produced in the 
fiber as well as the scintillation radiation generated. The model includes 
photon propagation in the fiber through to the signal at the photon detectors 
affixed to each end of the scintillation fiber. This model helps determine the 
relative contribution of Cherenkov radiation to the scintillation signal when 
parameters are varied. Those parameters include incident beam properties 
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such as energy, beam angle, field size, and modality (x-ray photons or 
electrons) and detector properties such as the fiber width, fiber length, fiber 
cross-sectional shape, scintillation spectrum, and detector spectral efficiency 
profile. Results of these simulations for electron beams and x-ray beams have 
shown the impact on scintillation light output and a metric for Cherenkov 
noise, the fraction of Cherenkov photons contaminating the total light output, 
for a variety of parameter combinations. 
In the second application, the objective is the characterization of 
Cherenkov radiation emitted from patient skin during external beam 
radiation therapy. To realize this objective, I constructed a Monte Carlo 
program for the beam interactions in skin that lead to the production of 
Cherenkov photons. This model will help determine the subsequent 
Cherenkov photon wavelength distribution, propagation and emission from 
the skin surface, and the position on the skin surface, while considering the 
wavelength-dependent absorption by molecular absorbers and scattering by 
tissue structures. The backscattered Cherenkov photons from skin are 
compared to two cases: Cherenkov photons in water and incident optical 
photons backscattered from skin. Results of the simulations show the 
position and emission direction of Cherenkov light generated in skin as well 
as the wavelength distribution. These results are compared to the same 
properties from simulations of Cherenkov radiation in a water medium and 
backscatter from optical light incident on the skin medium. 
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 Background 
This section provides a background overview of the Cherenkov radiation 
effect. Explaining Cherenkov radiation in detail makes clear its distinction 
from other radiative effects of high energy particle travel, such as the 
radiation associated with atomic electrons undergoing excitation and 
ionization or Bremsstrahlung x-rays produced by particle acceleration near a 
nucleus. This overview covers the history of Cherenkov radiation, the theory 
and equations for it developed by Frank and Tamm, and various other 
applications of Cherenkov radiation. 
Mallet observed Cherenkov radiation in 1926, in advance of the discovery 
by Vavilov and Cherenkov in 1934, but did not continue with the work 
beyond 1929 and assumed it was a type of fluorescence.3  Mallet observed 
bluish white light from a gamma-ray source placed in water, and 
measurements taken with film showed over a five-fold increase in darkening 
of the film relative to the exposure directly caused by the gamma-ray source. 
Furthermore, the radiation was found to mostly have short wavelengths by 
comparing the intensity after filtering with glass, which absorbs most 
photons of shorter wavelength than near-ultraviolet, compared to the 
intensity after filtering with quartz, which is transparent to ultraviolet light. 
Mallet’s additional spectral measurements from the years 1928 to 1929 
showed that the radiation was continuous and that it extends continuously 
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up to wavelengths of 436 nm, the upper limit of the spectral measurements 
performed. 
Vavilov and Cherenkov are credited with discovering the Cherenkov 
radiation effect, also called Vavilov-Cherenkov radiation, in 1934. After 
initially working with luminescence of salts in solution, Cherenkov found 
that gamma-ray radiation could also induce pure solvents to emit light.4  The 
observed glow was attributed to a new physical effect, rather than to 
luminescence, because they found no detectable excitation lifetime after a 
series of quenching experiments that are typically used to measure the 
excitation lifetimes of luminescent materials. Experiments with an applied 
magnetic field and beta particles showed that the radiative glow was caused 
by electrons traversing the solvent and that the intensity depended upon the 
electron beam direction. From those experiments, the presence of anisotropy 
in the intensity distribution of the electromagnetic waves led Frank and 
Tamm to develop a theory for the observed effect based upon the Huygens 
principle for propagation of wave fronts. 
In 1937 Frank and Tamm developed the theory for Cherenkov radiation, 
which provides results that change very little, when later on, higher order 
terms were included based on quantum theory.3  From the original theory, 
the equation for Cherenkov radiation output as electromagnetic energy 𝑊 per 
unit time is 
𝑑𝑊
𝑑𝑡
=
𝑒2
𝑐2
∫ (1 −
1
𝛽2𝑛2
)  𝜔 𝑑𝜔 
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where 𝑒 is the electric charge, 𝑐 is the vacuum speed of light, 𝛽𝑐 is the 
electron speed, 𝜔 = 2𝜋𝜈 for the frequency, and 𝑛(𝜔) is the refractive index of 
the medium. There is a threshold for Cherenkov production that requires 
that the refractive index 𝑛(𝜔) > 1/𝛽, which typically restricts the spectrum to 
ultraviolet, visible, and infrared wavelengths for transparent media. The 
equation can be expressed in terms of the number of photons 𝑁 emitted per 
unit pathlength 𝑟 by changing 𝜔 to units of wavelength 𝜆 and taking the 
energy per photon as ℎ𝑐/𝜆 such that 𝑊 = 𝑁 ℎ𝑐/𝜆 and integrating over a 
spectral range from 𝜆1 to 𝜆2 in which 𝑛(𝜔) is approximately constant. The 
resulting equation is 
𝑑𝑁
𝑑𝑟
= 2𝜋 𝛼 (
1
𝜆2
−
1
𝜆1
) (1 −
1
𝛽2𝑛2
) 
where 𝛼 = 𝑒2/(2𝜋 ℎ𝑐) ≈ 1/137 is the fine structure constant. 
The number of photons per unit wavelength interval varies proportionally 
to the inverse wavelength squared, for values of 𝑛(𝜔) that are approximately 
constant. This explains the typically bluish-white appearance of Cherenkov 
radiation generated by charged particles traversing water and other 
transparent media. As wavelengths go into the far-ultraviolet the value of 
𝑛(𝜔) approaches 1 and the number of Cherenkov photons tends to vanish due 
to the (1 − 1/𝛽2𝑛2) term and the threshold 𝛽 > 1/𝑛. Thus, for most 
transparent media, the spectral characteristics of Cherenkov radiation fall 
into the near-ultraviolet and visible spectrum because the spectral 
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distribution is bounded at short wavelengths by the change in 𝑛(𝜔) and at 
long wavelengths by the 𝑑𝑁/𝑑𝜆 ∝  1/𝜆2 relationship. 
The Cherenkov relation for the emission angle relative to the particle 
track, 
cos 𝜃 =
1
𝛽𝑛
 
depends only on 𝑛 the index of refraction and the particle velocity 𝛽𝑐, and the 
emission is symmetric about the azimuth of the axis formed by the particle 
path. The minimum velocity threshold for production of Cherenkov radiation, 
when expressing the speed as relative to 𝑐, is 
𝛽min =
1
𝑛
 
where the emission angle goes to zero. The maximum emission angle occurs 
as 𝛽 → 1 at an angle of 𝜃max = cos
−1(1/𝑛). 
A variety of experimental applications using measurement of Cherenkov 
radiation have existed since the beginning of the 1950s shortly after 
Cherenkov counters were proposed following the development of 
photomultiplier tubes.3, 4  Cherenkov counters consist of a radiator that 
produces Cherenkov radiation from a charged particle passing through it and 
an optically coupled photomultiplier tube that receives the Cherenkov 
radiation and produces a signal.4  In contrast to Geiger counters, Cherenkov 
counters do not have dead-time because the light is generated and propagates 
directly to the photomultiplier tube, and the two components of the 
Cherenkov counter can be optically coupled in such a way that the direction 
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of the detected particle can be determined. In 1951 Cherenkov counters were 
first used to detect single, high-energy, charged particles, followed in the 
same year by the direct measurement of the particle velocity of high-energy 
accelerator beams, and later in 1955 Cherenkov detectors were involved in 
discovering the anti-proton.3  The requirement of charged particles exceeding 
a threshold speed does limit Cherenkov counters to only certain applications 
though, such as in high energy physics experiments that measure single 
particle interactions in large water tanks like muon production and neutrino 
interactions.4  However, applications of Cherenkov radiation detection are 
not limited to just Cherenkov counters. An example is in measuring 
atmospheric cosmic-ray showers, where cosmic radiation entering the 
atmosphere results in ionization of the gases in the atmosphere.4  The 
electrons generated by atmospheric ionization produce Cherenkov radiation 
at radiofrequencies, which allows remote observation of electromagnetic 
showers at radio-astronomy stations. Those are a few of the long existing 
applications of Cherenkov radiation, and this dissertation will look at two 
recent applications in the form of Cherenkov radiation generated by 
megavoltage radiotherapy beams. 
 Thesis Organization 
A brief outline of the remaining chapters in this dissertation follows. 
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• Chapter 2 is a literature review. It is divided into two sections: first, a 
review of scintillation fiber applications in medical physics, then a review 
of Cherenkov imaging in medical physics. 
• Chapter 3 covers the Monte Carlo simulations of the scintillating fiber 
detector. This chapter is entirely self-contained as a paper and follows the 
formatting of a manuscript for the Medical Physics journal. 
• Chapter 4 moves on to simulations of Cherenkov emission from cutaneous 
tissue, and this chapter is also a self-contained article that also follows the 
same manuscript formatting as Chapter 3. 
• Chapter 5 appends additional results for Cherenkov emission from 
cutaneous tissue. The chapter focuses on simulations of an incident beam 
of electrons with comparisons to the Cherenkov emission that results from 
an incident x-ray beam. 
• Chapter 6 concludes the dissertation in general with a discussion of the 
results and recommendations for future research. 
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CHAPTER 2: LITERATURE REVIEW 
 Scintillation fibers 
Plastic scintillation dosimetry uses the scintillation light, corresponding to 
dose received in the scintillator, to determine the dose delivered to a medium, 
and an early setup used simple plastic scintillation blocks optically coupled to 
an optical fiber to transmit the signal to a photodetector outside of the 
radiation field1-3, which had the inherent problem of also collecting 
Cherenkov radiation generated in the optic fiber inside the radiation field. 
The advantage of plastic scintillators are that they are water equivalent, 
having very similar atomic composition, density, and electron density to 
water.3  Furthermore, the small size and water equivalence of the scintillator 
means that its presence in a water medium does not perturb the radiation 
beam passing through the plastic scintillator, making it ideal for 
radiotherapy QA dosimetry where measurements are made at depths in 
water. 
Burlin cavity theory predictions of the scintillator/water dose ratio were 
experimentally tested and confirmed for radiotherapy beams, measured at 13 
MeV to 19 MeV by Clift et al4, with the scintillator/water dose ratio measured 
as 0.962 +/- 0.008 in that energy range compared to the theoretical prediction 
of 0.963 +/- 0.002. The results confirmed that the scintillator detectors would 
be water equivalent for megavoltage photon beams, and only a single 
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correction factor would be required for dosimetry measurement based on a 
calibration of the detector. 
Dealing with Cherenkov radiation was approached in several ways. Clift 
et al5 used techniques to minimize the Cherenkov contribution to the signal 
by using scintillators with reflective coating to amplify the signal, long-
wavelength shifted scintillators to separate the signal from the short-
wavelength Cherenkov contamination, and absorbers to selectively absorb 
light with wavelengths outside of the scintillation emission spectrum. 
Fontbonne et al6 developed a method using spectral differences between 
Cherenkov light and the scintillation light and separate the green and blue 
components of the signal from a single scintillating fiber to determine the 
scintillation signal by comparing the measured channel ratio to a calibrated 
channel ratio, with accuracy within 1% of the expected dose. A method used 
by Lambert et al7 removed the Cherenkov signal by employing an air-core 
optical fiber – a plastic clad core of air, which does not generate Cherenkov 
photons – for the in-field portion of the fiber. The drawback of an air-core 
optical fiber is that the Cherenkov photons are highly attenuated when 
passing through that portion of the fiber. While the contaminating Cherenkov 
light found in solid-core optical fibers was not generated, the signal from the 
plastic scintillator was extremely attenuated. 
Scintillating fiber arrays, replacing the optical fiber and scintillator block 
with a scintillator doped optical fiber, has been studied by several 
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researchers8-15, but no solution to account for the Cherenkov component of the 
signal has allowed real time evaluation of the dosimetric measurement with 
high spatial resolution. The existing research in this field relies on CCD 
detectors that require extensive time to process the data or else a detector 
setup requiring an undoped optical fiber to collect Cherenkov radiation for 
background subtraction, resulting in the loss of spatial resolution. Other 
dosimeter types, using ion chamber arrays16, are able to monitor the dose 
during delivery but lack the ability to resolve the spatial distribution of the 
delivered radiation beam that a scintillating fiber array has the ability to do. 
A similar system that uses scintillating fibers instead of ionization chambers 
was developed by Lamanna et al17, who developed a detector prototype using 
a closely-packed array of scintillating fibers as a 2D homogeneous sheet to 
image a plane of the beam in real-time, but the resolution was limited to the 
size of the photodiodes used, which causes large artifacts in the image of non-
rectangular fields.  
Our research group has developed a prototype high resolution real time 
scintillating fiber detector18 that allows us to determine in real time the 
accuracy of stereotactic radiosurgery (SRS) and stereotactic body 
radiotherapy (SBRT) treatments by attaching in transmission mode at the 
output port of a micro-MLC, with the motivation of enhancing dose delivery 
accuracy and to achieve error free radiosurgery. A high-density array of 
scintillating fibers with a pitch of 0.5 mm and a high-speed photo detector 
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array with readout speed of 1.2 msec and 0.5 usec response time were 
integrated to implement a high resolution real time dosimeter that can 
sample pulsed SRS and SBRT beams cross sections. The high efficiency of the 
developed system allows reading each linac pulse in real time and computing 
the accumulated dose and dose errors smaller than 3% when less than 
1/100th of the beam is delivered. 
A second prototype our group developed19 of the in vivo transmission 
scintillation fiber detector was developed utilizing a set of 60 parallel 
scintillating fibers that were coupled to match the multi-leaf collimator 
(MLC) leaf pairs so that the beam fluence between each leaf-pair could be 
monitored in real time. The detector system is for large fields and can be 
mounted in the accessory tray of a linac gantry head, and the scintillating 
fibers are long enough to capture a projected 40 cm wide field. The detector 
was found to respond linearly with dose, independently of beam energy, and 
independent of the dose rate, while the polymer substrate the fibers are 
embedded in attenuates only 2.65% of the beam. Real time in vivo beam 
monitoring is possible with this system to enhance patient safety and 
treatment delivery accuracy by detecting dose errors from each MLC leaf 
pair. 
A third prototype variation of the in vivo transmission scintillation fiber 
detector20 was designed for standard-MLC-based SBRT and cone-based SRS 
real time treatment delivery monitoring with the system being mounted in 
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the linac accessory tray. A set of two high-density scintillating fiber linear 
arrays are layered to form an X-Y grid and captures the linac pulses in real 
time during treatment delivery while the detector rotates through 360 
degrees to capture angular beam projections. The reconstructed beam profiles 
are produced in real-time with sub-millimeter spatial resolution and 1% dose 
output resolution. This detector system has the ability to detect dosimetric 
errors of less than 1%, allowing SBRT and SRS treatments to be delivered 
error free. 
 Cherenkov imaging in tissue 
High energy electrons traveling through any dielectric medium, including 
human tissue, will generate Cherenkov radiation. The theoretical 
relationship between radiation dose and Cherenkov radiation emission 
should ideally be constant with the energy of the particle, and one study of 
this used analytic and Monte Carlo methods to relate Cherenkov photon 
generation position and dose deposition position for various radiation beam 
sizes, modalities (bremsstrahlung, Co-60, and electron beams), and 
energies.22  Cherenkov radiation generation per volume element was found to 
be predictive of dose deposited in that element. However, as indicated by the 
study’s authors, although they scored the positions in the Monte Carlo 
simulations, the directionality of the Cherenkov photon was not considered. 
Since the Cherenkov radiation emission direction is anisotropic, Cherenkov 
radiation visualization is angle dependent. The study was not able to 
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establish the relationship between visualization of the resulting Cherenkov 
radiation in a particular location to the absolute dose deposited in that 
location. However, if the anisotropy can be removed the Cherenkov radiation 
would theoretically predict the dose and allow visualization of the dose in real 
time. 
Anisotropy was effectively removed from Cherenkov radiation in a study 
using a water tank with a fluorescent dye doping the water, which absorbed 
the Cherenkov radiation and undergoes isotropic re-emission, and treatment 
plan quality assessment using Cherenkov radiation optical dosimetry was 
shown to be feasible with the water tank and a CCD camera.23  In that study 
the authors focused on relative dosimetry of dynamic IMRT and VMAT 
treatment plans where superposition of parallel opposed beams mitigates the 
variations in the energy fluence spectrum with depth that results in 
disproportionality between absorbed dose and the Cherenkov photon 
generation with depth. To counter the anisotropic emission of Cherenkov 
radiation, the water tank was doped with a fluorescent dye to absorb the 
Cherenkov radiation and re-emit isotropic light. The resulting image sets 
were summed to visualize the full beam over the entire rotational treatment. 
The summed Cherenkov image was found to match the intensity of the 
planned dose distribution when projected into the same viewing plane. 
In contrast to the treatment plan quality assurance methods described 
previously, another recent study used pulsed CCD imaging of Cherenkov 
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radiation surface emissions from patient skin during radiation therapy for 
real time visualization of the beam modulation and positioning.24  That study 
correlated high intensity Cherenkov emission locations to excessive dose hot 
spots on the skin surface that resulted in patient skin reactions, indicating 
that the method is successfully able to use the Cherenkov light intensity 
emitted from patient skin to predict the skin surface dose. The authors also 
noted that the visualization of major arteries in the images, caused by 
absorption of the Cherenkov photons passing through the vasculature, allows 
the possibility of checking patient positioning to within 1 to 2 mm over the 
course of the treatment. This study would indicate that the technique feasibly 
could perform relative dosimetry in vivo and during treatment. However, 
absolute dosimetry using the Cherenkov emissions at the superficial surface 
has yet to be achieved, which would require modeling the optical interactions 
in skin to account for the anisotropic emission of Cherenkov radiation. 
An evaluation of the concept of Cherenkov imaging for patient positioning 
validation and movement tracking took place in a phase 1 clinical trial.25  
During each treatment fraction a set of Cherenkov images were obtained, and 
this was done for several separate treatment fractions for each patient, and 
the sets were then analyzed. Positioning validation for inter-fraction setup 
error was done by comparing the beam-edge apparent on the Cherenkov 
images from each individual fraction to the average of the set of images over 
the whole treatment, and blood vessels that appeared in the images also 
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served as markers for the image registration algorithm. Retrospective 
movement tracking of respiratory motion matched each frame of the image 
set in a fraction to the average, thereby providing a measure of the amplitude 
of patient motion during the treatment. The results were consistent with the 
expected values, and they further found that the blood vessel visualization 
showed volume deformations in the treatment region, suggesting an 
application of Cherenkov imaging in deformable image registration. 
In terms of modeling the light transport through tissue, one example of a 
methodology is the Kubelka-Munk method.26, 27  The Kubelka-Munk method 
would specifically model the light incident on skin and account for 
subsequent interactions throughout different layers that ultimately scatter 
back out of the skin. For external beams of optical radiation, as assumed in 
the Kubelka-Munk model, the light source is entirely external from the 
patient skin. This will not work well in our case because the passage of high-
energy electrons generates optical light throughout the entire volume of skin 
rather than starting with a source plane at the skin surface. 
A model that accounts for the three-dimensional source with anisotropic 
scattering and a continuous wavelength distribution in a material with 
wavelength-dependent optical properties may best be solved using Monte 
Carlo techniques. There are numerous sources of semi-empirical and 
experimentally derived data of optical properties of skin and muscle tissues, 
and a recent review article28 included a collection of data from many sources. 
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One example of a three-dimensional Monte Carlo algorithm, Monte Carlo 
Simulations using Voxel Library (MCSVL),29 uses a wavelength-dependent 
optical property library in a voxel-based simulation in the trans-illumination 
imaging of skin lesions. The trans-illumination uses a ring light source 
against the skin surrounding the region of interest that transversely scatters 
through the skin before being reflected out for imaging at the site of the 
lesion. While most simulations assume that skin consists of layers where 
each layer has homogeneous properties, the MCSVL algorithm uses voxel-
based optical properties to represent the nonhomogeneous tissue structures 
that are difficult to model using mathematical equations for the irregular 
shapes found in skin surface lesions. 
Since the focus of this research is to characterize the Cherenkov radiation 
emitted from skin tissue as the beam enters the skin, a simple model of 
homogeneous layers can be used. Monte Carlo simulations in this research 
are based on optical propagation techniques in homogeneous layers of skin 
tissue as developed by Prahl et al30 and using optical properties summarized 
in a review by Jacques.31  Therapeutic laser treatment of superficial tumors 
by heating motivated the literature in this area. While their works focused on 
a beam incident on the skin surface and the thermal effects throughout the 
tissue, the converse is applicable to this research, where we are interested in 
light generated throughout the tissue that is ultimately emitted from the 
surface back into the air. 
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CHAPTER 3: Contribution of Cherenkov radiation in 
scintillator fiber detectors 
 
Purpose: To quantify and predict the Cherenkov radiation produced 
inside plastic scintillating optical fiber dosimeters used in real-time, in vivo 
dosimetry of clinical radiotherapy beams. 
Methods: We developed a Monte Carlo algorithm to model polymer 
scintillating fiber fluorescence and Cherenkov emission when irradiated with 
megavoltage radiotherapy beams. The model accounts photon generation 
cross-sections, wavelength-sampling, optical capture at the core-cladding 
interface, and transport efficiency through the fiber by incorporating indices 
of refraction, optical attenuation spectra, and the fiber geometry and 
dimensions. We study the Cherenkov emission dependency on dosimeter’s 
fiber cross section dimensions, shape, scintillation emission spectrum, 
characteristic spectral sensitivity profiles of a SiPM and a photodiode 
detector, incident beam’s energy, ionizing radiation modality (photons or 
electrons), and relative orientation between fiber and ionizing radiation. 
Results: Cherenkov radiation outside of the wavelength range of the 
scintillation spectrum but falling within the spectral sensitivity range of the 
photodetector contributed a substantial amount of Cherenkov to the total 
signal; 61% and 67% of the total Cherenkov emission is detected by a 
photodiode fell outside of the BCF-12 and BCF-60 scintillation spectra, 
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respectively. We found square fibers capture 1% as much of the generated 
Cherenkov light as scintillation light at the fiber cladding interface for a 
normally incident 6 MeV electron beam compared to 37% with round fibers. 
Decreasing the fiber width below approximately 1x1 mm began to decrease 
the transmission efficiency, losing 8% of scintillation light at 0.5x0.5 mm and 
an additional 15% at 0.25x0.25 mm, while larger fiber widths would reduce 
the spatial resolution of the system. 
Conclusions: Our analysis of the results suggests an optimal 
scintillating fiber dosimeter require a photodiode with optical filtering 
restricted to the emission wavelength range, using a green-shifted fiber such 
as the BCF-60 square fiber with edge width near 1x1 mm. For a normally 
incident photon beam, the system will produce approximately 1% Cherenkov 
radiation in the signal, and additional optical filtering may reduce that to 
0.33%. 
 Introduction 
Plastic scintillators are excellent dosimeters with water equivalent dose 
response, energy-independent response, and no polarization or density 
effect.1-3  The general configuration of a fiber scintillator dosimeter active 
sensor consists of a plastic scintillating fiber attached to a non-scintillating 
optical fiber to transmit the light to a photodetector placed outside of the 
radiation field and the signal processing electronics. Single sensors or array 
of sensor are typically used for clinical photon and electron beam dosimetry. 
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In a fiber sensor, Cherenkov radiation is generated in the scintillating and 
non-scintillating fiber exposed to the ionization radiation, and it will 
propagate through the fiber which will add spurious signal to the sensor 
output which is not proportional to the delivered dose. Cherenkov photons do 
not reflect the true energy deposition in the optical fiber because only a 
portion of the measured beam secondary electrons has energy greater than 
the Cherenkov production threshold. 
 Consequently, correction of the output to separate Cherenkov’s radiation 
from the scintillating emission is required to achieve accurate dosimetry in 
high energy clinical beams. Several methods have been developed to reject 
Cherenkov light contamination.4-7  A common correction method is to 
subtract the blue Cherenkov component from the signal by determining this 
emission from a second, parallel non-scintillating optical fiber.1  While the 
plastic scintillating fiber-optic detector has excellent spatial resolution and is 
shown to be appropriate for small field dosimetry,8 the requirement of a 
second parallel fiber limits the practical scope of the optical fiber dosimeters 
to low gradient fields and adds great complexity to the design and 
implementation of fiber arrays such as arrays matched to the linac MLC 
leaves  for real time dosimetry and in vivo treatment error detection.9, 10 
To improve upon the design, various techniques can minimize the 
Cherenkov contribution such as using long-wavelength emitting scintillators 
to spectrally separate the signal from the short-wavelength Cherenkov 
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emission and using optical filters to selectively absorb light outside of the 
scintillation emission spectrum.11, 12  These considerations reduce the impact 
of Cherenkov radiation on dose measurement accuracy but do not eliminate 
the Cherenkov signal completely. However, the Cherenkov photons will 
produce an almost constant component across all the scintillating center 
emission which can be eliminated using electronic thresholding13. 
The general conclusion of the previous work is an analysis of the factors 
affecting the scintillation and Cherenkov signal generated and transmitted in 
a doped or non-doped fiber is a key element in the design of dosimeters based 
in scintillating fiber sensors. Results by Lee et al14 and Jang et al15 quantify 
the Cherenkov radiation generated in scintillation fibers by electron beams 
as a function of beam angle, beam energy, and field size. Those results show a 
maximum Cherenkov contribution at a certain beam angle that falls off to 
zero at normally incident angles, although these results only hold for electron 
beams. 
Through modeling and simulation, here we expand the scope of the 
mentioned authors work to examine the role of several factors in the design of 
scintillating fiber sensors, such as the fiber’s scintillation emission spectrum, 
cross section dimensions, shape, active length; the ionizing radiation’s 
energy, modality (photons or electrons), and relative orientation of the fiber 
with respect to the ionization radiation beam; and the photodetector’s 
spectral sensitivity profiles and efficiency, that influence the signal from 
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organic scintillating fibers. The product of this study is to provide a guide for 
development scintillating fiber detectors capable of real time transmission 
detection of linac output with accurate dosimetry by controlling the 
Cherenkov photons.  
In our model and simulations, we follow the propagation vector of the 
linac and account for the Cherenkov component arising from each pulse, 
allowing real time dosimetry of the beam output without the loss of 
resolution occurring in the subtraction method or the loss of real-time 
detection occurring in methods requiring data post-processing. These results 
provide insights into role of the various factors that would aid in the design 
and development of improved detection systems. 
Megavoltage electrons passing through the interface between an organic 
optical fiber sensor and air will generate Cherenkov radiation in the optical 
range and a fraction of it will be trapped in the fiber and propagate though it 
until it reaches the detector. In a fiber is doped with a scintillating dye 
molecule, electrons will generate a scintillation signal proportional to their 
energy loss and this effect which is linear with the dose delivered is used to 
detect and measure radiation beams dose deposition. The Cherenkov 
radiation spectrum is continuous and its photon distribution per unit of 
wavelength is inversely related to the wavelength squared. Therefore, the 
number of photons increases as the wavelength decreases giving Cherenkov 
radiation the characteristic blue that spans from the deep blue to the 
 30 
 
scintillation center emission spectrum and across the visible spectrum of 
light. 
 Methods 
II.A. Cherenkov emission characteristics 
Cherenkov photons are emitted when a charged particle (electrons) 
travels through a dielectric medium faster than the phase velocity of light, 
which is the ratio of the speed of light in vacuum, c, to the refractive index, n, 
of the medium. The emission threshold in terms of the electron’s relative 
velocity is min  vmin/c = 1/n, which is related to the kinetic energy, T, 
through the equation,  
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and the kinetic energy threshold for Cherenkov radiation emission is found 
by relating the kinetic energy to its speed through the Lorentz factor as 
follows in Equation 2,  
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A charged particle emits Cherenkov radiation only at a particular cone 
defined by the angle p respect to the electron's path,  
   1cos   np . 3 
For a given medium with index of refraction n, the relative emission angle 
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depends only on the electron energy through the relativistic velocity . 
Electrons with energies near the production threshold will emit forward 
directed Cherenkov photons, while at increasing energies ( 1 ) the emission 
angle will approach a maximum defined by the arc-cosine of the inverse of 
the refractive index where the charged particle is propagating. 
II.B. Physics and geometry of the formulated Cherenkov emission 
and propagation model 
We model a mono-energetic beam of either x-rays or electrons incident on 
an organic polymer scintillating fiber embedded between a pair of 3 mm thick 
plates of acrylic (figure 1). For a beam of x-rays, interactions in the materials 
produce secondary electrons; for a beam of electrons, interactions begin upon 
entering the surface of the acrylic plate; and, in both cases, the same model is 
used for electron propagation inside the acrylic plate and fiber volume. 
Electrons, primary or secondary, interacting with the scintillating fiber 
generate both scintillation photons and Cherenkov photons. An optical 
photon’s propagation vector determines if the photon will undergo total 
internal reflection in the interface between the fiber core and shaft coating or 
will escape the fiber. For each captured photon, we compute the weight 
fraction surviving fiber core inherent absorption and the weight fraction 
detected by either of the photodetectors placed at the fiber ends. 
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Figure 3-1:  Diagram of the detector containing a round scintillation fiber 
embedded between two plates of acrylic. 
 
The developed model has several input parameters such as the 
scintillating fiber diameter for circular and side for square cross sections, 
fiber active length, and scintillator emission spectra. We model two photo-
detector technologies, a photodiode with a peak quantum yield of 0.9 
electrons per photon at 850nm and a silicon photomultiplier (SiPM) with a 
photon detection efficiency of 48% at 450nm. The incident beam source is 
modeled as a point source with a variable distance and orientation relative to 
the fiber. Algorithm input arguments allow varying the intersection point of 
the beam on the fiber and the fiber irradiated length, the primary beam 
particle, and the nominal beam energy. 
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Each simulated primary particle propagation vector is randomly sampled 
from the permissible vectors defined by each input parameter’s range to 
create a divergent beam. For an electron beam, each electron starts at the 
intersection point of the initial propagation vector and the top plane of the 
acrylic plate. For an x-ray beam, the mean free path of x-rays is large 
compared to the depth of the acrylic plate, so we improve simulation 
efficiency with forced interactions within the detector volume to only model 
the subset of x-ray interactions occurring within the plate with a statistical 
probability proportional to the photon track length intersection with the fixed 
geometry of the acrylic plate and polystyrene fiber core. Random sampling 
along this restricted track length determines the interaction site, and the 
statistical weight is passed down to the subsequently generated secondary 
electrons and the Cherenkov and scintillation photons arising from those 
electrons. We sample Compton electron emission angle from the Klein-
Nishina cross-sections, and we sample the photoelectron angle from a 
uniform isotropic distribution under the assumption that inaccuracies for 
photoelectrons are negligible for our overall results given the low probability 
of photoelectric interactions in the energy range of interest. 
The electron traverses the fiber through a series of interactions which are 
randomly modeled using the interaction probabilities for Cherenkov, soft 
collisional energy loss, and Coulomb scattering interaction events. Each 
interaction defines the electron path vector to the new position, and the 
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energy loss is simulated according to the rate of energy deposition according 
to the type of interaction. The free path lengths are small enough to assure a 
simulation equivalent to the continuous approximation. Electrons stops are 
ended when they escape from the acrylic plate or the electron’s energy is null. 
For electrons inside the fiber, Cherenkov photon or scintillation photons are 
generated according to the type of interaction which is determined by the 
sampling probability of these competing effects. 
We model continuous energy loss as the electron propagates through the 
medium with collisional stopping power data from the NIST ESTAR 
database. We model Coulomb scattering differential cross section using   
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This equation assumes the conditions for the Mott-Born approximation for a 
point nucleus with no shielding16 and is valid for energies above 0.036 MeV 
and scattering angles larger than 0.035 radians. The total cross section is 
implemented as a function of  and T, the kinetic energy, with the solid angle 
integrated for the bracketed term in advance and evaluated numerically as a 
function of 2 over the range of  from 0.035 radians to . Scatter at angles 
smaller than 0.035 radians is ignored. Results of the electron interactions as 
a function of the electron energy are shown in figure 2. 
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Figure 3-2. The rate of electron interactions in polystyrene fiber core 
material per unit pathlength as a function of the electron’s kinetic energy 
in MeV. Scintillation is shown for an average scintillation yield of 7100 
photons per MeV of deposited energy. Cherenkov photons are restricted to 
the wavelength range of 300 nm to 1200 nm, which is the upper spectral 
response of a silicon photodiode and does not account for 25% of the total 
Cherenkov light that would be produced above 1200 which is out of the 
detector range. Electron scatter accounts only for elastic scattering by soft 
Coulomb collisions. 
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The model uses the Frank-Tamm formula for determining the Cherenkov 
photon generation probability,17 integrated over the wavelength range of 
interest. Permeability  and index of refraction n are assumed to vary 
negligibly over the corresponding range of angular frequencies and are 
treated as constants during the integration. In this approximation, we have  
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where the number of Cherenkov photons emitted in the considered 
wavelength range per unit pathlength of electron travel is dN/dr, and  is 
the fine structure constant. We have assumed negligible electron energy loss 
over the path length because optical photons have energy on the order of a 
few eV. 
The sampling method for Cherenkov radiation wavelengths uses an 
inverse-transform of the Frank-Tamm formula over our wavelength range as 
follows  
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and depends only on the minimum and maximum wavelength of our chosen 
range. The Cherenkov wavelength spectrum for various values of  is shown 
in Figure 3. 
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Figure 3-3. Cherenkov radiation spectrum over the wavelength range of 
interest in the model, 300 nm to 1200 nm. The spectrum is shown for 
electron velocities from 0.7c, just above the threshold for Cherenkov 
radiation production, in 0.1c increments up through 1.0c, the theoretical 
maximum electron velocity, although for clinical 6MV beams, the 
maximum is 0.997c and the minimum energy to produce Cherenkov 
radiation occurs at 0.15 MeV. The shaded region of the figure overlaps the 
scintillation light produced with clinical beams. 
 
Cherenkov radiation is emitted at a specific polar angle, p, relative to the 
velocity vector of the electron (Figure 4). We assume the azimuthal angle, p, 
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is uniformly distributed from zero to 2 in the plane perpendicular to the 
velocity vector. Since these angles are relative to the unit propagation vector 
of the electron,  
 zyxe eeeΩ ˆˆˆ eee nml  , 7 
where the values of l, m, and n are the vector cosines to the respective 
coordinate axis, the unit propagation vector for the emitted photons in the 
same coordinate system is  
 zyxp eeeΩ ˆˆˆ ppp nml  , 8 
and the cosine factors are calculated using the following set of equations:  
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Figure 3-4. The emission angles of Cherenkov photons are distributed in a 
cone with its axis along the propagation vector e. p is the photon vector 
and p is the cone emission angle  
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Capture of an optical photon occurs when the photon undergoes total 
internal reflection at the fiber core-cladding interface. Light inside the 
scintillating fiber travels in a straight path through the core material until it 
reaches the surface of the core. The cladding, which surrounds the core, has a 
lower index of refraction, which allows the incident light to undergo total 
internal reflection for angles larger than the critical angle. The incident angle 
at the inner surface of a square fiber can be determined from the dot product 
of the normal unit vector ns of the surface and the outgoing photon unit 
vector. The internally reflected photon propagation vector is calculated from 
the incident photon unit vector as follows,  
   ssinp,inp,outp, nnΩΩΩ ˆˆ2  . 10 
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Figure 3-5: The reflection angles of Cherenkov photons at the fiber 
boundary are determined by the surface normal (surface perpendicular to 
x-axis shown here) and remain constant for a given photon. 
 
Since the dot product of two unit vectors is the cosine of the angle between 
them, the incident angle at the fiber wall in the x-dimension, x, and z-
dimension, z, is the inverse cosine of the photon propagation vector's x and z 
component's absolute value, respectively, with a similar result for the 
incident angle for round fibers, r,  
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Incident and reflection angles are identical to the initial angle of incidence 
and reflection in both square and round fibers. If both the x and z for square 
fibers or r for round fibers are greater than the critical total internal 
reflection angle, the Cherenkov photon will propagate in the core through a 
series of total internal reflections until reaching the photo-detector. Our 
model calculates the first incident angles and then assigns the photon as 
either captured or escaping, and no explicit optical photon propagation 
algorithm is needed. 
From the initial propagation vector, we also account for photon 
attenuation of captured photons using implicit absorption weighting along 
the fiber. The photon's pathlength and the wavelength-specific attenuation 
coefficient determine the probability of transmitting the photon to the 
detector without absorption in the fiber core, and that probability is then 
assigned as that photon’s transmitted statistical weight contribution to the 
total intensity in the output files. The statistic weights of the transmitted 
photons are further modified by the wavelength-dependent photodetector 
efficiency. 
 Technical characteristics of simulated fibers and 
detectors 
The modeled fibers are Saint-Gobain formulations BCF-60 and BCF-12. 
The primary difference between these formulations is the scintillation yield, 
7100 and 8000 scintillation photons per deposited MeV respectively, and 
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wavelength emission spectra which are shown in Figure 3-6 and peak at 530 
nm and 435 nm respectively. Both types of fibers have a polystyrene core 
with an average index of refraction of 1.60, and the cladding material is 
acrylic with n = 1.49. The polystyrene core has a density of 1.06 g/cm and its 
atomic density composition for hydrogen and carbon is H =4.82X1022 cm-3, 
C = 4.85 x1022 cm-3, and electron density e = 3.4x10 23 cm-3. The 
manufacturer specified 1/e length, which is the length required to attenuate 
the overall intensity of the emission spectrum to 1/e of the initial value, is 3.5 
m and 2.7 m respectively for the BCF-60 and BCF-12 fiber formulations. 
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Figure 3-6. Normalized emission spectra for the BCF-12 and BCF-60 
scintillator fibers. BCF-12 has a broad spectrum that peaks at 435 nm in 
the blue region of the visible spectrum and BCF-60 has a narrow emission 
in the green region of the visible spectrum with a maximum at 530 nm. 
 
We have modeled the optical transmission properties of polystyrene 
(Figure 3-7) based on semi-empirical models and descriptions of photon 
transmission through polystyrene-core polymer optical fibers.18, 19  We use a 
wavelength-dependent equation based on a combination of the UV absorption 
tail, a Rayleigh scattering curve, and specific IR absorption peaks modeled 
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with Lorentzian distributions. In addition to the material absorption, we 
account for photon losses for each reflection at the fiber-cladding boundary by 
calculating the expected number of reflections a photon will undergo and 
implicitly absorbing 0.1% of that photon’s weight for every reflection. This 
small power loss adjustment is dependent on the manufacturing process, 
representing losses due to imperfections in the fiber cladding,20 and is 
therefore based on trial and error to arrive at the correct 1/e length as 
specified by the manufacturer for both scintillation distributions we modeled. 
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Figure 3-7. Transmission distribution used in the simulation based on a 
semi-empirical model of the bulk material properties of polystyrene. The 
plot shows the transmitted fraction of an initially uniform wavelength 
distribution after propagating through 100 cm of polystyrene material. 
 
The photon detection efficiency from device specifications was interpolated 
in the model, and Figure 3-8 shows the photon detection efficiency as a 
function of wavelength for the photodiode and the SiPM. For the SiPM the 
photo-detection efficiency was specified from 350 nm to 640 nm in 10 nm 
increments with linear interpolation and was linearly extrapolated to zero at 
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either end. The photodiode was specified over the entire response range in 
50 nm increments and interpolated with cubic splines with linear 
extrapolation to zero. 
 
Figure 3-8. Modeled photodetectors. The photodiode was modeled with 
cubic spline interpolation of the data points, and it has a wide spectral 
sensitivity range with a 0.62 A/W peak spectral sensitivity at 850 nm. The 
SiPM was modeled with linear interpolation, and it has a narrow 
sensitivity range with a 0.48 peak detection efficiency at 450 nm. The 
curves are normalized to their peak value. Signal output for a photodiode 
is typically 1-10, while the silicon photomultiplier output increases with 
gain on the order of 106. 
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 Results 
We performed simulations using the combination of parameters shown in 
Table I. For each fiber set up, labeled as simulation types, we varied a 
parameter or combination of parameters over a set of several simulations as 
follows. First, in simulations of type 1, we tested the angular dependence of 
the fiber shapes by varying the gantry angle in 5 degree intervals for square 
fibers and then repeated with round fibers, and we also selected the beam 
modality from between 6 MeV electrons and 6 MV x-rays. In simulations of 
type 2 we simulated different components of the detector so that each fiber 
type was paired with each detector type, resulting in four combinations. In 
simulations of type 3 we studied the energy dependence of Cherenkov 
radiation by varying the initial beam energy from 1 MeV up through 20 MeV. 
We varied the fiber width from 0.25 mm to 2 mm in the simulations of type 4. 
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Table 3-I. Simulation model parameters. 
Parameter Sim type 1 Sim type 2 Sim type 3 Sim type 4 
Beam energy 6 MeV 
electrons & 6 
MV photons 
6 MV 
photons 
1-20 MeV 
electrons 
6 MV 
photons 
Source to 
fiber distance 
100 cm 100 cm 100 cm 100 cm 
Irradiated 
fiber length 
10 mm 10 mm 10 mm 10 mm 
Detector type Diode Diode & 
SiPM 
Diode Diode 
Fiber type BCF-60 BCF-60 & 
BCF-12 
BCF-60 BCF-60 
Fiber shape square & 
round 
square square & 
round 
square & 
round 
Fiber width 1 mm 1 mm 1 mm 0.25-
2.00 mm 
Gantry angle -85 to 
85 degrees 
0 degrees 0 degrees 0 degrees 
 
IV.A. Simulation type 1: fiber shape variation 
For the first set of simulations, we investigated the role of the impinging 
beam angle. The fiber axis passed perpendicularly through the plane defined 
by the gantry axis of rotation and the vertical beam central axis. The fiber 
length extended 22.5 cm from the isocenter to the photodiode detector in the 
direction of 90 degrees gantry angle. We varied two angle-sensitive 
parameters: fiber shape with round and square cross-sections, and the beam 
varied between 6 MV x-rays and 6 MeV electrons. For the four combinations 
of those parameters, we investigated the range of gantry angles from -85 
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degrees to 85 degrees in 5 degree intervals and plotted in Figure 9 the 
percent of Cherenkov radiation in the total light detected at each angle. 
 
Figure 3-9. The percent of Cherenkov photons in the detected light in a 
square fiber and round fiber at different gantry angles for 6 MeV electrons 
and 6 MV photons. The detecting photodiode is at 22.5 cm from the 
isocenter in the direction of the gantry position at 90 degrees, and the fiber 
passes through the isocenter. 
 
To verify the simulation results for x-rays, we measured the Cherenkov 
radiation generated inside an un-doped optical fiber coupled to a PMT 
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(Hamamatsu R6358P), irradiated using 6MV x-rays from an Elekta Versa 
linear accelerator. The measured output in Figure 10 agrees with our 
simulation results over the angles of greatest Cherenkov generation. 
 
Figure 3-10. Experimental measurements of light output from an un-doped 
optical fiber irradiated by 6MV x-rays and coupled to a PMT follow the 
predicted curve from simulations. 
 
IV.B. Simulation type 2: scintillation spectra and photodetectors 
In the type 2 set of simulations, each scintillation fiber spectrum type was 
paired with each photon detector type for a total of four combinations. The 
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simulation set up was the same as type 1 simulations, but we selected only 6 
MV photon beams and a fixed gantry angle at 0 degrees. We tabulated the 
number of photons per MeV for each combination along with the percentage 
of Cherenkov radiation. This output was the sum of photons detected at each 
end of the fiber, and the center of the fiber was coincident with the isocenter. 
Table 3-II. Photon detection numbers show the signal per MeV and 
Cherenkov photon contribution to the total signal for each of the pairings of 
BCF-60 and BCF-12 with the two photodetectors. 
Photon 
detector 
Fiber type Total photons 
per MeV 
Scintillation 
photons 
per MeV 
% Cherenkov 
photons of 
the total 
photons 
Diode BCF-60 423.3 420.2 0.74% 
Diode BCF-12 371.0 367.9 0.84% 
SiPM BCF-60 226.0 224.7 0.60% 
SiPM BCF-12 288.1 289.5 0.47% 
 
Additionally, we computed the Cherenkov spectrum detected in the 
simulation for each detector type (Figure 3-11). The Cherenkov spectrum was 
sharply limited by the range of the SiPM, which accounts for the short 
wavelength Cherenkov photon detection of that detector. Absorption peaks at 
long wavelengths, arising from attenuation in the fiber core material, appear 
in the Cherenkov spectrum detected by the diode. 
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Figure 3-11. The spectrum of Cherenkov photons detected by the 
photodiode and the SiPM. 
 
Scintillation light is emitted over a smaller wavelength range than the 
sensitive range of the photodetectors (comparing Figure 6 and Figure 8). In 
Table III, we calculate, based on the results in Figure 11 and the known 
scintillation spectrum ranges in Figure 6, the percentage of Cherenkov 
photons with shorter or longer wavelengths than the scintillation spectra. 
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Table 3-III. Cherenkov distribution relative to the scintillation emission 
spectra for the two detector technologies paired with each of the two fiber 
formulations. The percentage of Cherenkov light with shorter wavelengths 
than the shortest scintillation wavelength and with longer wavelengths 
than the longest scintillation wavelength depends on the detector sensitive 
range and the scintillation distribution range. 
Detector Fiber Shorter 
wavelengths 
Overlapping 
spectrum 
Longer 
wavelengths 
SiPM BCF-12 15.6% 65.4% 19.0% 
SiPM BCF-60 46.3% 47.9% 5.8% 
Diode BCF-12 5.9% 39.9% 54.2% 
Diode BCF-60 20.7% 42.7% 36.6% 
 
IV.C. Simulation type 3: incident beam energy 
In the third set of simulations, we varied the initial particle energy from 
1 MeV up to 20 MeV for a normally incident beam of electrons. The resulting 
curve is plotted in Figure 12. A sharp slope near the Cherenkov production 
threshold at low energy rose to the maximum detected fraction of around 
1.4% in square fiber at 1.25 MeV and 1.6% in round fiber at 1.5 MeV. As 
energy increased beyond 1.5 MeV, the Cherenkov component decreased. Our 
simulation results revealed that the fiber cladding capture fraction of 
Cherenkov light approached the knee of its asymptotic value by 
approximately 3 MeV. 
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Figure 3-12. The fraction of Cherenkov photons in the detected light for 
electrons with incident energy of 1 to 20 MeV. 
 
IV.D. Simulation type 4: fiber width variation 
Type 4 simulations evaluated variations in fiber width, defined as the 
diameter of round fibers and edge-length of square fibers, and 6 MV x-rays 
were normally incident on the fiber, with output measured in detected 
photons per absorbed MeV inside the fiber core. The output curves of square 
and round fibers were normalized to equality at 1 mm fiber width. 
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Figure 3-13. The number of photons detected per absorbed MeV decreases 
with decreased width of the fiber, where the width is diameter for round 
fibers and edge length for square fibers. 
 
 Discussion 
V.A. Theoretical validation 
Using tables of the continuous slowing down approximation (CSDA) 
ranges of electrons to calculate absorbed dose in a thick foil21, we estimate 
the energy deposited in the simplest case of a square shaped scintillating 
 57 
 
fiber from a perpendicular electron beam. First, we identify the energy of the 
electrons entering the polystyrene core of the fiber after passing through the 
0.25 cm (0.30345 g/cm2) plate of PMMA above the fiber which is the typical 
material thickness used in line transmission detectors. The CSDA range of 6 
MeV electrons in PMMA is 3.162 g/cm2. Assuming 2% path lengthening due 
to scattering, the energy per electron entering the PS core will average 5.415 
MeV, which has a CSDA range in polystyrene of 2.85255 g/cm2. The 0.10 cm 
(0.106 g/cm2) deep polystyrene fiber, assuming 1% path lengthening due to 
scatter, reduces the remaining range to 2.74549 g/cm2 upon exiting the fiber, 
which corresponds to an average energy of 5.211 MeV per electron. The 
remaining energy will be deposited along the path through the lower PMMA 
plate before exiting into air. The energy difference between entrance and exit 
energy per electron, corrected for radiative losses, is an average of 0.197 MeV 
locally deposited in the polystyrene fiber core per electron. 
Averaging repeated simulations of a 6 MeV electron beam at normal 
incidence on the fiber produced an average of 0.197 MeV +/- 0.001 MeV 
deposited in the fiber per electron. The electron processes in our simulation 
agrees with theory for this restricted test case. 
V.B. Analysis of the main results and impact on the design and use of 
scintillator dosimeters in medical linear accelerators 
In the design of an efficient scintillating fiber detector, we are particularly 
interested in the amount of Cherenkov radiation being detected with the 
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scintillation signal. We use as a comparison metric the fractional Cherenkov 
component, the amount of Cherenkov light detected divided by the total light 
detected. We observed variation in the Cherenkov component with variation 
of impinging beam angle, the beam energy, and different parings of 
photodetector technologies and scintillation formulation. 
The impinging beam angle had the greatest Cherenkov component when 
the beam pointed toward the detector end of the fiber, because Cherenkov 
radiation is emitted in a forward-directed cone in the direction of the 
detector. Electron beams peak at 9.6% Cherenkov component at 40 degrees in 
square fibers and 9.1% Cherenkov component in round fibers. X-ray beams 
are muted in comparison; the peak Cherenkov component of square fibers is 
4.1% and of round fibers is 3.9%. In all combinations of fiber shape and type 
of beam, the Cherenkov component is less than 0.9% when the beam pointed 
toward the non-detecting end of the fiber, and the electron beam irradiating a 
square fiber in particular had a Cherenkov component of less than 0.1%. 
For clinically relevant field sizes with the detector at a fixed position 
relative to the beam, the incident beam would have an impingement angle 
from approximately -10 degrees to +10 degrees. The Cherenkov component of 
x-ray beams would be approximately 0.4% to 1.4% in that range for square 
fibers and 0.5% to 1.5% for round fibers. 
We found that the diode photodetector technology was more sensitive to 
light in general than the SiPM detector, but the diode does have a larger 
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Cherenkov component than the SiPM regardless of the scintillator spectrum 
it is paired with. Of the two scintillator spectra, we found the green-peaked 
BCF-60 had a higher detected light output than the blue-peaked BCF-12 
scintillating fiber, regardless of detector pairing. Pairing the BCF-60 and 
diode photodetector produces the best output, and after analyzing the 
spectral distribution of Cherenkov radiation, we found only 43% of the 
detected Cherenkov light was inside the wavelength range of BCF-60. The 
idea of a band-pass filter that removes light outside of the wavelength range 
of the scintillator is appealing because it would eliminate over half of the 
detected Cherenkov light in that combination. 
The Cherenkov component was sensitive to incident beam initial energy 
at low energies but became relatively constant for high energy beams because 
the Cherenkov emission angle approaches its asymptotic value beyond 3 
MeV. The peak value for a normally incident beam of electrons in a square 
fiber was 1.4% at an electron energy of 1.25 MeV and for a round fiber was 
1.6% at 1.5 MeV. For clinically realistic beams of at least 6 MeV, at normal 
incidence, the Cherenkov component was less than 0.1% in square fibers and 
on average 0.6% in round fibers. 
The fiber width parameter had no measured effect on the Cherenkov 
component. Decreasing fiber widths decreased scintillation light transmission 
and Cherenkov transmission equally. The quantity of interest we found with 
fiber transmission was transmission losses, which was more sensitive for 
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round fiber diameter than square fiber. In particular, decreasing the fiber 
width from 1 mm to 0.5 mm caused a decrease in light output per absorbed 
MeV of 14% in the round fiber compared to only 8% in the square fiber. 
 Conclusions 
We are able to compute Cherenkov generation in real time scintillating 
fiber dosimeter geometries. The computations incorporate the major design 
parameters of the scintillating fiber dosimeter system, including the fiber 
dimensions, shapes, and emission spectra and the detector spectral response 
to the transported light. Variations on these parameters allow the design and 
optimization of high efficiency dosimeters that are capable of operating in 
real time to enhance patient safety and treatment accuracy of external beam 
radiotherapy. A variety of beam energies and beam angles enable the 
analysis of the dosimeter signal for various setups using either electron 
beams or photon beams, providing a range of results for each variation of the 
parameters used in the design of the scintillating fiber dosimeter. 
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CHAPTER 4: A two-layer cutaneous tissue model of 
external beam radiotherapy induced Cherenkov emission 
 
Purpose: Quantitative imaging of the emitted Cherenkov light is a 
putative method to study skin ionizing radiation effects using the optical 
properties of the Cherenkov light emitted from patient’s skin exposed to an 
MV external therapy beam of x-rays or electrons. We model the angular, 
spectral, and surface distribution of the Cherenkov intensity to determine its 
relation with cutaneous melanin and hemoglobin oxygenation state. 
Methods: To characterize the emitted Cherenkov light distribution, we 
developed a tissue model simulating the interaction of a primary MV beam 
with skin and the optical interactions of the emitted Cherenkov light with 
affected skin layers. The cutaneous model consists of a semi-infinite dermal 
region and an overlying thinner epidermal layer. The algorithm stresses the 
distinct optical absorption and scattering occurring in each tissue medium. 
Results: The spectrum of Cherenkov light emitted from the irradiated 
skin surface shows absorption bands corresponding to hemoglobin absorption 
lines from the dermal layer, originating from the process of ionizing radiation 
penetration to the dermal region and generation of back propagated 
Cherenkov radiation across the dermis. The resulting spectrum of Cherenkov 
radiation has wavebands at 454-500nm and 586-796nm that are sensitive to 
biological changes in tissue oxygenation. We quantified the oxygen saturation 
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sensitivity ranging from 0% to 100% for Cherenkov radiation in these bands 
and parameterized this sensitivity for variations of the melanosome volume 
fraction typical of the human epidermal layer ranging from 1.3% to 45%. 
Conclusions: Cherenkov emission from the irradiated skin surface 
depends on the concentration of oxygenated and deoxygenated hemoglobin in 
the dermis and the melanosome content of the epidermis, which allowed us to 
estimate the sensitivity of certain wavebands to oxygen saturation for 
detecting skin response to treatment of skin lesions such as keloids or skin 
cancers. Optimal waveband selection depends on the melanin content of the 
skin, with short wavebands providing the strongest signals from lightly 
pigmented skin. 
 Introduction 
An emerging method of real-time dosimetry in external beam megavoltage 
radiation therapy is based on the Cherenkov photons emitted from the 
patient’s skin during the treatment arising from interactions of high energy 
electrons and the skin tissue. It has been shown that the Cherenkov light 
intensity can be directly imaged with high-efficiency ICCD and EM-ICCD 
optical cameras to verify accurate treatment delivery while the beam is on1. 
Additional to dosimetry, the relationship between Cherenkov light intensity 
with the incident treatment beam fluence or skin dose can provide additional 
information of the skin interaction to ionizing and skin biological properties.2 
Estimating the intensity and spectral characteristics of Cherenkov light 
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generated within the tissue offers great challenges. While in Cherenkov 
based dosimetry, intensity emission is the quantity of interest, the emission 
spectrum (absorption) can provide information about patients’ radiation skin 
reactions, skin tissue composition, and oxygenation. 
To determine the usefulness of Cherenkov emission for dosimetry, the 
theoretical relationship between radiation dose and Cherenkov radiation 
generation has been studied2 using analytic and Monte Carlo methods for 
various radiation beam sizes, modalities (bremsstrahlung, Co-60, and 
electron beams), and energies, although the absorption and scattering of 
Cherenkov light was not included in previous studies. Here, to accurately 
account for Cherenkov emission from skin as a surrogate for skin-ionizing 
radiation interaction and skin composition, the Cherenkov radiation 
generation and its optical transport through tissue is explicitly modeled using 
a parametrization of the skin optical and ionizing radiation absorption and 
scattering properties. 
 Methods 
Monte Carlo is used to simulate the ionizing radiation interactions with 
the medium, water or skin, as well as propagating the optical photons 
through the medium to the point of emission at the air-skin surface. We 
report the estimated distributions of Cherenkov photons that are emitted 
from the surface of the medium. 
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We focused on the cutaneous layer by restricting the model to a practical 
range of 30mm, which comprises the maximum back propagation distance 
expected from secondary electrons generated by a 6MV beam. The initial 
statistical weight of secondary electrons are scaled by the interaction 
probability across this 30mm depth, and is fully accounted for in the 
subsequent Cherenkov light distributions as a function of skin depth.  
II.A. X-ray interactions 
We consider a beam of 6MV x-rays entering the tissue at normal incidence 
as shown in Figure 1. The beam undergoes photoelectric interactions and 
Compton scattering interactions. 
To minimize statistical variance in our results while sampling relatively 
rare photoelectric events, for an x-ray’s first interaction event we split the 
statistical interaction weight of secondary electrons between an electron 
generated after a photoelectric event and an electron from a Compton 
scattering event, which has an energy-dependent directional distribution. 
The scattered Compton photons undergo further interactions to generate 
additional electrons until the photons are absorbed in a photoelectric event. 
Photoelectric events count for less than 1% of interactions above 0.2 MeV, 
which is the electron energy threshold to produce Cherenkov radiation, so 
photoelectric interactions were accelerated in the simulation by sampling 
photoelectron trajectories from an isotropic distribution and ignoring binding 
energy. In the case of Compton scattering events, we based the Compton 
 68 
 
electron’s trajectory and energy on the well-known Klein-Nishina cross-
section formula3.  
We modeled both skin layers as homogeneous material with uniform 
radiation characteristics from the ICRP skin composition data as weight 
fractions: H[0.100588], C[0.228250], N[0.046420], O[0.619002], Na[0.000070], 
Mg[0.000060], P[0.000330], S[0.001590], Cl[0.002670], K[0.000850], 
Ca[0.000150], Fe[0.000010], and Zn[0.000010]. Other ICRP properties used in 
the model are the physical density, 1.10 g cm-3, and the mean ionization 
energy, 72.7 eV.4, 5 Interaction probabilities for x-rays are based on data from 
the NIST XCOM Photon Cross Sections Database4 using the composition 
data.  
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Figure 4-1. Diagram of the two-layer skin model with a 0.1 mm thick 
epidermal layer overlying the dermal layer. 
 
II.B. Electron interactions 
The x-rays produce secondary electrons, which then interact throughout 
the medium and will produce Cherenkov radiation if Cherenkov emission 
constraints – electron energy above 219-keV for a medium with a 1.4 
refractive index – are satisfied6. We chose to use the typically selected 
refractive index of 1.47, which factors into both the Fresnel refraction 
equations and the Frank-Tamm formula,  
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with units of Cherenkov photons per unit pathlength. The constant , 
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approximately 1/137, is the fine structure constant, the wavelength range of 
interest is the interval [1, 2], n is the medium’s refractive index, and =v/c 
is the relative electron velocity. 
The particle tracking for electrons included interactions for soft collisions, 
Coulomb scattering, and Cherenkov radiation production using the Frank-
Tamm formula. For energy deposition by electron interactions, we 
interpolated the stopping power tables from the NIST ESTAR database5 as 
an approximation of the energy lost by soft collisions. For the electron 
scattering process, we use Coulomb scattering based on the Mott-Born 
approximation with no shielding and a point nucleus.8  
II.C. Optical interactions 
The Cherenkov radiation propagates through the medium, undergoing 
absorption, scattering, and surface reflection which are modeled using optical 
absorption coefficients and anisotropy factors found in the literature7, 9-12. The 
skin was divided into two homogeneous layers: the epidermis and the 
underlying dermis to compute the optical photon propagation. We used a 
thickness of 100 microns for the epidermis, and the remaining depth for the 
dermis7. Each layer has separate optical absorption coefficients, scattering 
coefficients, and anisotropy factors.  
We modeled the optical absorption in the epidermal layer and the dermal 
layer as the absorption by major molecular absorbers found in each layer 
using the methodology developed by Prahl9 and tissue values calculated from 
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the work by Jacques (figure 2).12 The epidermal layer optical absorber is 
melanin, which varies significantly in the human population, with 
melanosome volume fraction ranging from 1.3% to 43%7. The dermal layer 
absorber is hemoglobin, in the oxygenated and deoxygenated state, with a 
dermal molarity of 4.7 M and typical oxygen saturation of 40%. To 
accelerate our model so that each sampled wavelength contributes to as much 
volume as possible, we use implicit absorption during transport to gradually 
reduce the photon statistical weight until reaching the weight-based 
termination threshold of 10-3, at which point absorption interactions are 
sampled competitively against scattering interactions with photon 
termination occurring upon the sampling of an absorption event. 
 
  
 72 
 
 
Figure 4-2. Wavelength-dependent optical interaction coefficients for human 
skin in the visible range and extending out to 1000nm. Epidermal absorption 
occurs by melanin, dermal absorption occurs by a mixture of oxygenated 
hemoglobin (HbO2), deoxy-hemoglobin (Hb), and water. Reduced scattering 
coefficients for the epidermis and dermis are also shown. 
 
The wavelength dependent scattering interaction probability for the 
dermis and the epidermis was determined using reduced scattering 
coefficient data from each layer independently as reported in the literature11, 
12. The data for the reduced scattering coefficient, which characterizes 
attenuation by scatter, does not describe the directional distribution of the 
scattered photons, so the model contained a tissue specific anisotropy factor 
from literature data7, 10 to account for the full scattering interaction during 
the simulation. The anisotropy factor g for dermis is a constant 0.715 across 
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the visible range and in the epidermis is defined by the following exponential 
relation      0.1806/0.500exp1546.0745.0  g 10. We sampled the 
scattering angles  using those values of the anisotropy factor g and the 
Henyey-Greenstein phase function,  
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where  is a normalized uniform random number. 
Photons crossing the plane of the skin-air interface undergo partial 
reflection, splitting the photon statistical weight into a reflected and 
transmitted photon, with angles determined using Snell’s law, which set the 
fractional weight of the reflected photon from the Fresnel reflection 
coefficient13. The reflected photon propagated further throughout the tissue, 
while the transmitted photon carrying the remaining statistical weight 
contributes to the Cherenkov light intensity output estimation. We chose a 
photon propagation cut-off depth of 5mm by considering that fewer than 10-7 
optical photons would survive to reach the skin surface from beyond that 
depth, and to implement that cut-off we use a Russian roulette method to 
eliminate 90% of the particles crossing that depth. The extension of the 
transverse plane is determined by tracking optical photons until the photon 
was absorbed. 
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II.D. Comparison to skin surface diffuse reflection 
For comparison to diffuse scatter of ambient lighting, we replaced the x-
ray beam with an incident beam of optical photons with uniform distribution 
over the visual and near infrared spectrum, from 350nm to 1000nm. We 
record the photons that are backscattered out of the tissue. The resulting 
remission can be used to determine the signature of the Cherenkov properties 
relative to incident visible light, which have different spectra, initial 
distributions, and angular distributions, to explore the sensitivity of skin 
propagation to those parameters. 
II.E. Comparison to Cherenkov generation and emission in water 
For comparison and interpretation of results we replaced tissue with 
water in our model. The x-rays enter the water slab at normal incidence from 
the air slab, and we record the number of Cherenkov photons returning to the 
air-water surface, which allows comparison of the signature of the skin 
optical scattering and absorption in the Cherenkov emission.  
The radiological interactions in the water material are computed using 
the same algorithm as the tissue layers. Visible Cherenkov photon transport 
through the water medium are computed using the absorption coefficients for 
water14 shown in Figure 2. In tissue scattering occurs through a combination 
of Mie and Rayleigh scattering originating from the organized structures in 
cells that cause light to undergo one of these two modes of scatter15, but in 
pure water scattering arises from microscopic density fluctuations in the 
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medium caused by thermal molecular motion, which is described in the 
Einstein-Smoluchowski theory of scattering.16 The scattering coefficient b(), 
equation 4, is independent of the scattering angle,  
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with  in units of nm. The angular phase function (), equation 5,  
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is independent of the wavelength. The constant factors in each equation were 
evaluated based on a depolarization ratio =0.09 and normalization to an 
attenuation factor of 0.94 × 10-4 m-1 at  = 546nm and  = 180 degrees. 16 
 Results 
We simulated a square 1x1 mm2 normally incident x-ray beamlet 
containing 106 poly-energetic 6-MV photons. For our initial simulations we 
set the biological parameters to 2.5% melanosome fraction by volume in the 
epidermis and 40% oxygen saturation (SO2) of hemoglobin in the dermis. 
III.A. Cherenkov generation at depth 
Figure 3 displays the resulting Cherenkov intensity generated in tissue 
(3a) and water (3b). There is a Cherenkov buildup region near the surface 
where the electron fluence is low and a gradient at the edge of the beam 
where the fall off of lateral electron fluence causes loss of Cherenkov 
radiation. The total Cherenkov intensity shown in the figure is approximately 
 76 
 
34% higher in tissue than in water because we set the refractive index of 
tissue to 1.4 and the Frank-Tamm formula relates higher indices of refraction 
to increased Cherenkov emission. Additionally, the refractive index 
dependent threshold for Cherenkov radiation allows tissue to generate 
Cherenkov radiation at electron energies down to 219keV compared to the 
threshold of 289keV in water.  
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Figure 4-3. Cherenkov intensity distributions at the moment of generation in 
the media for radiation beamlets impinging at normal incidence into an air-
medium interface. For both figures the vertical axis shows depth in tissue, 
with the air boundary at the top (depth=0), extending downward to a depth of 
4mm, and the horizontal axis shows the transverse cross-section through the 
center of the 1 mm2 6-MV x-ray beamlet. The medium on the left (a) is tissue 
and on the right (b) is water. 
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III.B. Surface distributions 
We evaluated the lateral extent of the surface distribution of optical 
Cherenkov photons emitted from the skin surface. The surface isodose lines 
from 0.1x0.1x4.0 mm3 dose voxels, Figure 4a, have a steeper gradient than 
the emitted Cherenkov intensity contours in Figure 4b: the surface dose had 
a full width at half-maximum (FWHM) of 1.0 mm centered at the 1mm-wide 
beamlet center while the Cherenkov FWHM was 1.8 mm. Diffusely 
backscattered visible light in Figure 4c showed the effects of lateral optical 
scattering in tissue, and the FWHM was 1.0 mm. 
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Figure 4-4. Top down views of the air-tissue surface centered at the 1x1 mm2 
beamlet, with insets showing the horizontal profile line through the center of 
each corresponding plot. a) Isodose distribution contours showing the average 
dose in the upper 4 mm tissue layer for the 6 MV photon beam, b) the 
corresponding Cherenkov emission intensity from the tissue at the surface, 
and (c) backscattered light for a normal incidence optical beam. 
Normalization is to maximum intensity and the dimensions are in mm. 
 
III.C. Angular distributions 
For each case of study, the angular distribution of photons per unit solid 
angle, normalized to the total number of photons (figure 5), was forward 
scattered and had the highest intensity near the normal to the skin-air 
interface plane. The Cherenkov distribution in tissue was most forward 
scattered at 0.36 Sr-1 on average within the first 5 degrees from the normal. 
The optical beam’s backscattered distribution closely followed the Cherenkov 
emission, peaking at 0.34 Sr-1, and the Cherenkov emission from water was 
the least forward-peaked at 0.28 Sr-1. The curve for diffuse reflection from an 
ideal diffuse scattering material (0.32 Sr-1 peak) is shown for comparison. 
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Figure 4-5. Emitted intensity plot of the directional distribution per unit solid 
angle (Sr-1) of emitted light with 5 degree binning. The surface normal is 
designated as 90 degrees. Curves are each normalized to a total photon 
emission of unity before calculating the emission per solid angle. 
 
III.D. Spectral distributions 
Figure 6 shows a comparison of the simulated spectral distribution of the 
photon intensity emitted from the air-skin surface by Cherenkov light, from 
the air-water surface, and for diffusely scattered light from human skin. The 
two absorption bands shown in the spectra of the Cherenkov light emitted 
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from the tissue corresponds to the location of the dermal hemoglobin 
absorption peaks. Diffusely scattered light from the incident optical beam 
showed less pronounced hemoglobin absorption than the Cherenkov emission 
generated by the x-ray beam, and they are not present in Cherenkov 
radiation emitted from water. 
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Figure 4-6. The photon spectral distribution of the emitted light ranging in 
wavelength from 350nm to 1000nm for Cherenkov emission from the skin, 
Cherenkov from water, and diffusely reflected optical light from the skin 
model. The vertical axis is normalized to emitted photons per incident 
particle (either Cherenkov photons per x-ray or diffusely reflected photons 
per incident photon). 
 
III.E. Spectral sensitivity to dermal melanosome fractional volume 
The biological parameters have so far been set to 40% SO2 in the dermal 
hemoglobin and 2.5% melanosome volume fraction. Now we show results for 
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the simulation with variations in the epidermal melanosome volume fraction 
of 1.3%, 2.5%, and 5% to 45% in 5% increments.  
The spectrum of Cherenkov radiation is generated in inverse proportion to 
the cube of its wavelength, but the emitted Cherenkov radiation carries the 
spectral signature of optical chromophores, hemoglobin and melanin, in the 
tissue layers it passed through (figure 7). Two high transmission spectral 
regions appear: one near 500nm and the other beyond 600nm. Included 
within the first peak is the wavelength band from 454-500nm, which permits 
higher transmission through deoxygenated hemoglobin than through 
oxygenated hemoglobin. The second peak contains the wavelength band 586-
796nm, where oxygenated hemoglobin allows higher transmission than 
deoxygenated hemoglobin. 
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Figure 4-7. Cherenkov radiation spectrum emitted from skin with 10nm 
binning. Skin parameters are set to 40% oxygen saturation and a range of 
epidermal melanosome volume fraction from 0.013 to 0.45. 
 
III.F. Spectral sensitivity to dermal oxygen saturation 
To further investigate the two transmission bands in the previous section, 
we ran simulations varying the oxygenation of the dermal hemoglobin from 
0% to 100% in 5% SO2 increments. Hemoglobin oxygenation in skin can be 
spectroscopically measured because the absorption spectrum for hemoglobin 
differs for oxygenated and deoxygenated states of hemoglobin. Oxygenated 
hemoglobin absorbs more strongly over the wavelength band from 454-
500nm, and in that wavelength band the emitted Cherenkov radiation 
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decreased with increased dermal oxygenation (figure 8). In the 586-796nm 
wavelength band, where deoxygenated hemoglobin more strongly absorbs, 
the detected Cherenkov radiation increased with dermal oxygenation (figure 
9). The slopes of these lines indicate the sensitivity of each band to dermal 
hemoglobin SO2. Generally, increasing dermal oxygenation increases 
Cherenkov emission in the 586-796nm band while decreasing Cherenkov 
emitted at 454-500nm. 
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Figure 4-8. The Cherenkov intensity in the 454-500nm wavelength band as a 
function of oxygen saturation. The curves are parameterized to the 
melanosome volume fraction, ranging from 1.3% to 45%. 
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Figure 4-9. The Cherenkov intensity in the 586-796nm wavelength band a 
function of oxygen saturation. The curves are parameterized to the 
melanosome volume fraction, ranging from 1.3% to 45%. 
 
III.G. Cherenkov intensity estimates of oxygen saturation are 
sensitive to melanin 
The previous results show that the long wavelength band is more 
sensitive than the short wavelength band to changes in tissue oxygenation, 
but now we demonstrate that both bands are more sensitive to variations in 
melanin concentration than to tissue oxygenation. The data from the figures 
5 and 6 are re-plotted together as a function of melanosome volume fraction 
ranging from 1.3% to 45% (figure 10). For increasing amounts of melanin, the 
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decrease in oxygenation sensitivity of the 454-500nm wavelength band was 
74% less than the decrease in the 586-796nm wavelength band, but the 
overall sensitivity was higher for the 586-796nm wavelength band at each 
melanosome volume fraction. Sensitivity to changes in melanin was lower in 
overall magnitude for the 454-500nm wavelength band than for the 586-
796nm wavelength band regardless of the dermal oxygenation parameter.  
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Figure 4-10. Emitted Cherenkov intensity per incident particle as a function 
of melanosome volume fraction. Curves are plotted for fully deoxygenated 
hemoglobin (0% SO2), fully oxygenated hemoglobin (100% SO2), and the 
average over all SO2 values. The intensity curves are shown separately for 
Cherenkov radiation generated in the 454-500nm range and the 586-796nm 
range. 
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 Discussion 
The spectral distribution of Cherenkov light emitted from skin tissue 
resembles the spectrum of diffusely reflected light from skin more closely 
than it does the familiar Cherenkov spectrum seen from water (figure 6). 
Cherenkov emission is more sensitive to hemoglobin than diffuse reflection 
because diffusely reflected light includes a large amount of backscattered 
light from the epidermal layer, while Cherenkov light only passes through 
the epidermal layer when leaving the skin surface. As a spectroscopic probe 
of tissue oxygenation, Cherenkov radiation may be able to provide effective 
insights into biological response to radiation therapy. 
The sensitivity of Cherenkov radiation to changes in melanin is higher 
than the oxygen saturation sensitivity in the two broad wavebands analyzed, 
but radiation therapy does not significantly change the melanin-based 
absorption of skin during the treatment course17. Late response to treatment 
does cause statistically significant changes to occur after one year post-
treatment, associated with depigmentation, but during the treatment course, 
only the absorption by hemoglobin increases significantly.17 Erythema 
reactions may be more likely to occur following an approximately 20 
percentage increase in the oxygen saturation,18-20 so predicting skin reactions 
early in the treatment may be possible through Cherenkov imaging. 
The response to treatment of skin surface lesions, such as keloids and skin 
cancers, could be monitored using the change in oxygen saturation measured 
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using Cherenkov emissions. Keloids have approximately half the oxygen 
saturation of adjacent normal skin, and keloids that successfully respond to 
treatment will return to typical oxygen saturation values21. While melanoma, 
which has approximately 15 percentage lower oxygen saturation compared to 
adjacent normal tissue,22 is not usually treated with radiation, basal cell and 
squamous cell carcinoma can have approximately 5 percentage lower than 
typical oxygen saturation23. 
The ability to detect a 5% to 20% SO2 change in oxygen saturation 
depends on the contrast between the surface lesion and the surrounding 
normal tissue in the Cherenkov images. We simulated images for a circular 
3cm diameter keloid, defined by a 20% oxygen saturation lesion surrounded 
by normal tissue with 40% oxygen saturation (figure 11). The figure shows 
the expected contrast for differing levels of melanin in the skin, after 
adjusting the exposure time to rescale the normal tissue to equal intensities 
across the image series. Contrast decreases with increasing melanin. 
Contrast, defined here as the ratio of the difference in lesion and background 
intensity to the background intensity, is 2.18%, 1.93%, and 1.80% in the 586-
796nm waveband and 5.78%, 5.69%, and 5.27% in the 454-500nm for light, 
medium, and dark skin, respectively. The lesion will emit less Cherenkov 
radiation than the normal tissue in the 586-796nm wavelength band, while 
the lesion is brighter than the normal tissue in the 454-500nm wavelength 
band.  
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Figure 4-11. Cherenkov surface emission distributions in the 586-796nm 
waveband and the 454-500nm waveband, with 20% SO2 in the central 3cm 
diameter circle of each image and 40% SO2 baseline in the surrounding 
surface. The images are normalized to equal intensity in the 40% SO2 
surrounding surface, and the normalization factor shows the increasing 
relative imaging exposure time to compensate for absorption by increased 
melanin content and the sensitivity of each waveband. Variations are shown 
for light, medium, and dark skin containing, respectively, 2.5%, 15%, and 
30% melanosome volume fraction of the epidermis. The grayscale units are 
total emitted Cherenkov photons per mm2 for an incident 6MV beamlet of 
fluence 106 x-rays per mm2, multiplied by the relative exposure time shown 
above each image. 
 
We simulated lesion oxygen saturation typical of a basal or squamous cell 
carcinoma for the same image series by setting the lesion to 35% SO2 
compared to normal tissue 40% oxygen saturation (figure 12). In this case of 
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5% SO2 deficit, the contrast between the normal tissue background and the 
lesion is less than 1.5%. At 586-796nm wavelengths the contrast is only  
0.54%, 0.49%, and 0.46% for light, medium, and dark skin, respectively, while 
the 454-500nm wavelength band has contrast of 1.44%, 1.41%, and 1.31% for 
the respective skin types. These simulated images use ideal detection 
conditions, which ignores the effects of noise that degrades the visibility of 
low contrast objects. 
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Figure 4-12. Cherenkov surface emission distribution contrast for a central 
circular region of 35% SO2 and 40% SO2 surrounding baseline. Variations 
are shown for waveband (586-796nm and 454-500nm) and melanosome 
volume fraction (light, medium, and dark skin). Scaling matches the images 
in figure 11. 
 
To estimate the relative signal strength we evaluate the noise associated 
with Poisson photon statistics, which has a statistical variance equal to the 
mean number of photons. As a signal-strength metric, we calculate the 
estimated signal-to-noise ratio (SNR) for each case based on the Rose 
model24,  
 bnACSNR   16 
which depends upon the lesion contrast C, the lesion area A, and the average 
background photon density nb. The calculated SNR (Table I) varies with the 
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oxygen-deficit in each lesion type, for each waveband, and across the 
melanin-content of the skin. Notably the 454-500nm waveband signal 
strength for lightly pigmented skin is 13% higher than the 586-796nm 
waveband, while with medium pigmented skin the 586-796nm waveband has 
13% higher signal than the 454-500nm waveband. For the case of darkly 
pigmented skin the signal strength is 32% higher for the 586-796nm 
waveband than for the 454-500nm waveband. The optimal waveband to focus 
on for Cherenkov imaging in oxygen-deficit lesions depends on the melanin 
content of the skin. 
 
Table 4-I. Signal-to-noise ratio of Cherenkov radiation emission in de-
oxygenated skin lesions. Variation with melanin is parameterized into light, 
medium, and dark skin. Two principle wavebands, 586-796nm and 454-
500nm, are compared for each skin type. 
  Light Medium Dark 
20% SO2 lesion     
 586-796nm 106.6 68.0 44.0 
 454-500nm 120.3 60.5 33.2 
35% SO2 lesion     
 586-796nm 26.7 17.0 11.0 
 454-500nm 30.1 15.1 8.30 
 
Another consideration for Cherenkov imaging is the imaging angle. The 
directional distribution of Cherenkov light emitted from skin indicates the 
directional sensitivity for imaging Cherenkov radiation. Our simulations 
showed that Cherenkov light is emitted in the forward direction more than 
diffusely reflected light. For emission making an angle of 35 degrees or close 
to the surface, Cherenkov emission becomes less intense than the intensity 
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from an ideal diffuse scattering material. Ideal diffuse scattering results in 
equal radiance emitted in all directions (cm-2Sr-1), considering that the 
apparent size of the surface changes inversely with the cosine of the angle 
from the surface normal, but our results indicate that Cherenkov apparent 
intensity will continually increase with increasing angles from the skin 
surface and approach a maximum at the surface normal. The slight impact 
on apparent Cherenkov intensity from variations in the imaging angle may 
contribute to poor resolution of low-contrast surface lesions at large imaging 
angles from the surface normal. 
The lesion visibility in an image depends on the blur at the edges of the 
lesion. The Cherenkov emission area extends over a larger area of skin than 
the incident x-ray beam, which indicates some amount of blurring will appear 
in the images. Measurement of the Cherenkov radiation’s profiles shows a 
FWHM of 1.8 mm compared to the 1.0 mm FWHM of the skin surface isodose 
curves, or a loss of spatial resolution of approximately 0.4 mm from the 
radiation field edge. However, the impact of spatial resolution depends on 
both the lesion size and contrast. Surface lesions undergoing radiotherapy 
will typically be large enough that the loss of 0.4mm spatial resolution would 
negligibly affect lesion visualization. 
 Conclusions 
Cherenkov radiation generated in skin by an external beam of radiation 
provides a means of quantitatively measuring biological properties. Melanin 
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absorption in skin occurs in the epidermis, and the absorption coefficient is 
inversely proportional to the cube of wavelength. For this reason, diffuse 
reflectance spectral measurements using an external illumination source are 
limited to long wavelengths where melanin weakly absorbs because the 
incident light must cross the epidermis on the way into the body and again on 
the way out of the body. However, Cherenkov radiation generated throughout 
the irradiated tissues can carry the signal from the dermal tissues to the 
surface, passing through the melanin layer only once, which mitigates the 
loss at short wavelengths. Cherenkov radiation may provide a way to 
interrogate physiological parameters in the skin, particularly at short 
wavelengths. 
We investigated the emitted Cherenkov intensity from the skin surface in 
terms of the surface emission angle, the apparent position on the skin 
surface, and the wavelength distributions resulting from variations in the 
hemoglobin oxygen saturation and the melanin content of the skin. The 
spectral distribution of Cherenkov radiation emitted from tissue can support 
two distinct wavebands that allow oxygen saturation estimates and the 
possibility of tracking treatment progress of skin lesions. We also 
incorporated estimates for the loss of Cherenkov sensitivity with increased 
melanin content for each waveband. The estimated lesion contrast variation 
with oxygen saturation, parameterized by wavelength band and the amount 
of epidermal melanin, has a potential application in lesion response detection 
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during radiotherapy. For oxygen-deficit skin lesions in lightly pigmented 
skin, the 454-500nm waveband produces a stronger signal than the 586-
796nm waveband. In moderately to darkly pigmented skin the 586-796nm 
waveband produces the stronger signal. 
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CHAPTER 5: External electron beam induced Cherenkov 
emission from the two-layer cutaneous tissue model 
The previous chapter considered Cherenkov emission from skin 
undergoing irradiation with an external beam of 6MV x-rays generated from 
a medical linear accelerator, but often superficial treatments use an external 
beam of electrons. This chapter focuses on the same two-layer cutaneous 
model as the previous chapter, but the impinging 6MV x-ray beamlet is 
replaced with an impinging 6MeV electron beamlet. 
 Cherenkov emission for electron beams and sensitivity to 
tissue parameters 
We simulated a 1x1 mm2 electron beamlet, which contained 104 electrons 
with an initial energy of 6MeV, normally incident to the cutaneous layers. 
Each simulated electron traveled its full range in tissue and was terminated 
either after depleting its energy or once it backscattered into air. 
I.A. Cherenkov generation at depth 
The spatial distribution of Cherenkov intensity throughout the material 
varies with depth into the medium from the air-surface and with lateral 
distance from the center of the electron beamlet (figure 1, left). Compared to 
the distribution from x-ray beams (figure 1, right), the electron beams 
generate Cherenkov radiation nearest the surface with decreasing intensity 
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at depth, while x-ray beams have a build-up region throughout the depth of 
the skin. 
  
Figure 5-1. Cherenkov intensity distributions at the moment of generation in 
tissue for 6MeV electron beamlets (left) and 6MV x-ray beamlets (right). The 
top of each figure is the air-tissue interface (depth = 0) with depth on the 
vertical axis and the horizontal axis shows the lateral distance from the 
center of the 1mm wide beamlet. 
 
I.B. Surface distributions 
The surface distributions of the emitted Cherenkov photons are shown in 
figure 2 for the 6MV electron beam (figure 2, left) compared to the 6MeV x-
ray beam (figure 2, right). The difference between these two distributions is 
the gradient in the intensity distribution, with the electron beam having a 
sharper gradient than the x-ray beam. The full-width at half-maximum 
(FWHM) of the electron-beam-generated Cherenkov emission is 1.3mm. For 
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the x-ray-generated Cherenkov emission, the FWHM is 1.8mm. Considering 
the depth distribution of Cherenkov generation described earlier (figure 1), 
the difference in emitted Cherenkov surface distributions (figure 2) can be 
attributed to the proximity to the surface of the Cherenkov photons when 
generated, since lateral travel of scattering photons increases with the 
distance traveled to reach the surface. 
   
Figure 5-2. Top-down views of the air-tissue surface centered at the 1x1 mm2 
beamlet, with insets showing the profile through the center of each 
corresponding plot. (left) Surface intensity contours of the emitted Cherenkov 
light generated by the 6MeV electron beam. (right) Cherenkov emission 
intensity from the surface for the 6MV x-ray beam. Both plots are normalized 
to the respective maximum emitted Cherenkov intensity. 
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I.C. Angular distributions 
The angular distributions of emitted Cherenkov photons from skin (figure 
3) essentially follow the expected distribution for diffuse reflection from skin. 
Compared to a Lambertian surface having ideal diffuse scattering, the 
photons scattering from skin are more forward scattered; the photon 
intensity per steradian for skin is greater than for a Lambertian surface at 
angles within 50 degrees of the surface normal. After normalizing the 
number of photons emitted to unity, Cherenkov emission with a 6MeV 
electron beam peaks at 0.35 Sr-1 and with a 6MV x-ray beam at 0.36 Sr-1, 
compared to 0.34 Sr-1 for diffusely scattered light from skin or a Lambertian 
surface at 0.32 Sr-1. 
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Figure 5-3. Emitted intensity plot of the directional distribution per unit solid 
angle (Sr-1) of emitted light with 5 degree binning. The surface normal is 
designated as 90 degrees. The number of photons emitted are normalized to 
unity before calculating the emission per solid angle. Electron-beam-
generated Cherenkov emission (6e beam) is shown in comparison to the x-
ray-generated Cherenkov emission (6x beam). 
 
I.D. Spectral distributions 
The spectral distribution of Cherenkov photons emitted from the skin 
surface (figure 4) for electron-beam-generated Cherenkov photons closely 
matches the features found in x-ray beam generated Cherenkov photons, 
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after normalizing the simulated number of photons to unit photon emission, 
but there is slightly more Cherenkov attenuation at short wavelengths for 
Cherenkov radiation generated by x-ray beams. The reason may be that there 
is simply less attenuation of Cherenkov radiation electron beams where a 
much larger fraction of Cherenkov photons are generated closer to the 
surface than for x-ray beams. 
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Figure 5-4. The photon spectral distribution of emitted light, ranging in 
wavelength from 350nm to 1000nm, for Cherenkov emission from tissue after 
generation by a 6MeV electron beam and a 6MV x-ray beam, Cherenkov 
emission from water after generation by the 6MV x-ray beam, and the 
diffusely reflected light from scatter in tissue. The plots are normalized to 
unit emitted photon. 
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 Sensitivity of Cherenkov emission to surface lesion 
tissue parameters for electron beams 
Using a convolution-superposition beam algorithm based on the 1x1 mm2 
electron beamlet and the surface distribution of Cherenkov radiation 
emission, we produced images for a 3 cm diameter skin lesion (figure 8). The 
circular center lesion is defined by 20% oxygen saturation in the dermal 
layer, and the surrounding normal tissue plane was defined as 40% oxygen 
saturation. Three representative skin pigmentations were selected: light 
(2.5% epidermal melanosomes by volume), medium (15%), and dark (40%). 
For the 586-796nm wavelength band, the expected contrast between the 
lesion and the surrounding tissue was found to be 1.83% in light skin, 1.44% 
in medium skin, and 1.19% in dark skin. In the 454-500nm wavelength band, 
the expected contrast was higher at 4.40% in light skin, 4.13% in medium 
skin, and 3.81% in dark skin. 
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Figure 5-5. Cherenkov surface emission distributions in the 586-796nm 
waveband (top row) and the 454-500nm waveband (bottom row), with 20% 
SO2 in the 3cm diameter keloid lesion and 40% SO2 baseline in the 
surrounding normal tissue, which the grayscale values are centered around. 
Variation are shown for light (2.5% melanosome volume fraction), medium 
(15%), and dark (40%) skin. 
 
We are able to determine the best wavelength band for signal strength 
from different skin pigmentations. For estimating the relative signal 
strength, accounting for the effects of noise associated with Poisson photon 
statistics in addition to the image contrast, we used the signal-to-noise ratio 
(SNR) based on the Rose model to calculate the SNR for each of the six 
representative images of the 20% SO2 skin lesion (Table I). For light skin the 
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SNR was 6% higher in the 454-500nm wavelength band. In medium and dark 
skin, the 586-796nm wavelength band had a higher signal strength by 13% 
and 68%, respectively. Similar results were obtained for x-ray beams in 
Chapter 4, where the relative signal strength was 13% higher in the 454-
500nm wavelength band for light skin, and the signal strength was 13% and 
32% higher in the 586-796nm wavelength band for medium and dark skin, 
respectively. 
 
Table 5-I. Signal-to-noise ratio of Cherenkov radiation emission in de-
oxygenated skin lesions for an incident electron beam containing 104 
electrons. Variations with melanin are parameterized into light, medium, and 
dark skin for different epidermal melanosome volume percentages and for the 
586-796nm and 454-500nm wavebands. 
  Light, 2.5% Medium, 15% Dark, 40% 
20% SO2 lesion    
 586-796nm 187.8 105.1 58.6 
 454-500nm 198.4 93.2 34.9 
35% SO2 lesion    
 586-796nm 47.0 26.3 14.6 
 454-500nm 49.6 23.3 8.73 
 
 Conclusions 
Electron beams generate Cherenkov radiation that upon emission from 
the skin surface has similar angular, spatial, and spectral distributions to the 
Cherenkov radiation emitted from skin under irradiation by x-ray beams. 
The depth distribution of generated Cherenkov radiation follows the 
principles of the depth dose distribution for the x-ray beam and electron 
beam modalities; and most of the difference between the Cherenkov radiation 
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emitted by the two modalities is a consequence of the Cherenkov generation 
depth distribution. The angular distributions of Cherenkov radiation emitted 
by the two irradiation modalities are nearly identical, although x-ray 
generated Cherenkov radiation is slightly more intense in the direction of the 
surface normal. The surface distribution of Cherenkov radiation generated by 
electron beams has a sharper gradient than x-ray beam generated Cherenkov 
radiation. Cherenkov radiation emitted from the skin irradiated by electron 
beams has greater intensity at short wavelengths than Cherenkov emission 
that was induced by x-ray beams. These results are all consequences of 
shallow initial depths, which reduces absorption and scatter, of Cherenkov 
radiation produced by electron beams. 
Within the specific wavelength bands that are sensitive to hemoglobin 
oxygen saturation, Cherenkov radiation that was generated by irradiation 
with x-ray beams shows less sensitivity to the effects of melanin, and electron 
beams produce lower relative signal strength in the 454-500nm wavelength 
band than x-ray beams produce. This does not have a large enough effect to 
contradict the finding that the short wavelength waveband of 454-500nm 
does produce a higher signal for lightly pigmented skin than the 586-796nm 
wavelength band, which holds for the electron beam irradiation modality as 
well as the x-ray beam irradiation modality discussed in Chapter 4. 
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CHAPTER 6: General Conclusions 
 General Discussion 
Cherenkov radiation has been used in various applications since its 
discovery. Two applications relating to medical radiation dosimetry have 
been examined in this dissertation. In the case of Cherenkov radiation 
generated in organic plastic scintillation fibers, the Cherenkov radiation is 
contaminating noise in the scintillation signal, while in the case of Cherenkov 
emissions from an irradiated skin surface, the Cherenkov radiation provides 
measurable information that relates to the radiation entering the body 
through that surface and the molecular constituents of the irradiated skin. 
Monte Carlo simulations of the Cherenkov radiation in these media, with 
customized code written in the C programming language, have provided 
insights about the Cherenkov distributions that arise in these two practical 
applications. 
Based on the results from simulations using a variety of parameters, we 
optimize the design of the real-time scintillating fiber dosimeter. 
Recommendations based on the parameters that minimize the Cherenkov 
radiation include the following: 
• The fiber should be shifted to longer wavelengths beyond the peak 
region of the Cherenkov spectrum, as in the BCF-60 fiber. 
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• A high sensitivity photodiode detector improves with additional 
band filtering to eliminate signals outside the emission spectrum of 
the BCF-60 fiber. 
• Organic scintillating fibers with a square cross-section have a much 
lower fractional Cherenkov component than round cross-sectional 
fiber, and the transmission losses are lower when the fiber width is 
varied, making them more robust over a range of sizes. 
• Fibers with an edge length of less than 1 mm begin to have 
increased transmission losses, and while transmission losses 
decrease moderately for thicker fibers, there is a trade off with 
decreasing spatial resolution of the radiation field. 
A two-layer tissue model examined the spectral distribution, angular 
distribution, and cutaneous propagation of Cherenkov radiation emitted from 
the skin induced by external radiotherapy beams. The primary purpose of the 
model was to explore the predominant factors in these properties of the 
emitted Cherenkov radiation. The results show the following: 
• The wavelength distribution depends most strongly on the optical 
absorbers present in the dermal tissue, which are the oxy-
hemoglobin and deoxy-hemoglobin found in blood perfusion in those 
tissues. The fraction of hemoglobin in the oxygenated state – the 
oxygen saturation of the perfused dermis – directly controls the 
intensity of Cherenkov radiation emitted in specific wavebands, 
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particularly 454-500nm and 586-796nm. The oxygen saturation in 
abnormal dermal tissue conditions is known to deviate from normal 
by up to 5-percentage in skin carcinomas and up to 20-percentage 
in keloids; both are conditions treated with external beam 
radiotherapy, which is known to generate Cherenkov radiation. 
• In lightly pigmented skin, for x-ray beams and electron beams 
respectively, the 454-500nm waveband has a 13% and 6% higher 
signal-to-noise (SNR) ratio than the 586-796nm waveband. 
Moderately pigmented skin has a 13% higher SNR for the 586-
796nm waveband, and darkly pigmented skin has a 33% and 68% 
higher SNR for the 586-796nm waveband. 
• The angular distribution of Cherenkov radiation is only slightly 
more forward peaked than diffusely remitted light from tissue. 
Diffuse reflection and emitted light from tissue are slightly forward 
peaked relative to an ideal diffuse reflecting surface. Therefore, the 
angle used for Cherenkov imaging will not greatly affect light 
collection efficiency. 
• The full-width at half-maximum of Cherenkov light generated by a 
1.0mm x-ray beamlet is 1.8mm and for an electron beamlet is 
1.3mm, while the full-width at half-maximum of both the surface 
dose and diffusely scattered light are 1.0mm. A blurring effect of up 
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to 0.4mm at the edges of the Cherenkov emission would be 
expected, which is insignificant relative to typical tumor sizes. 
 Recommendations for future research 
The simulation results for the scintillating fiber dosimeter show 
variations of several fiber parameters, and experimental results with an un-
doped optical fiber validated the simulation results of the change in 
Cherenkov signal with incident beam angle. In the simulations at parameter 
values used in the detector prototype, we expect virtually no Cherenkov 
contamination, which indicates future work with the scintillating fiber 
detectors will not require corrections for Cherenkov contamination. 
Our simulations using the two-layer tissue model of Cherenkov radiation 
emission explored the variation in Cherenkov emission for biological 
parameters. Cherenkov signal was sensitive to oxygen saturation of the 
dermis, with distinct wavebands producing stronger signals depending on the 
amount of melanin in the epidermis. Future work to validate the results 
would require the preparation of a tissue-like phantom that mimics the 
radiological properties as well as the optical absorption and scattering in 
cutaneous tissue. 
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